Kusajili – Clinical trials directory

Result of your search per sponsor: Henri Roche, PhD

Woman Max 99 years
Henri Roche, PhD Update Il y a 4 ans

XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer The primary objective of the study is to assess the activity of XRP9881 in combination with trastuzumab. The secondary objectives are safety and pharmacokinetic interaction

Country Belgium, France, Sweden, Switzerland
organs None
Specialty None

Closed trial

More information